UPC APP 19773/2025

—

Verfahrensdetails: Status
—
Verfahrensart
Vorbescheid
Kategorie
Vorab-Einrede
Parteien: Kläger
Genevant Sciences GmbH
Arbutus Biopharma Corporation
Beklagte
Moderna Italy S.R.L.
Moderna France SASU
Moderna Germany GmbH
Moderna Poland SP. Z.O.O.
Moderna Netherlands B.V.
Moderna Denmark ApS
Moderna Biotech Spain SL
Moderna Belgium S.R.L.
Moderna Portugal Unipessoal LDA
Division: The Hague LD
Richter: —
Sprache: —
Erste Entscheidung: 23. Mai 2025

Entscheidungen

2025-05-23
ZuständigkeitPreliminary objection
Procedural order of The Hague Local Division in infringement proceedings by Genevant Sciences GmbH and Arbutus Biopharma Corporation against multiple Moderna entities concerning lipid nanoparticle delivery technology. The order addresses preliminary objections and jurisdictional matters concerning certain Moderna entities (Moderna Spain, Moderna Poland, Moderna Norway), examining whether their activities constitute or enable infringement within the UPC territory.
Rechtsfragen:Preliminary objectionJurisdiction over Moderna entitiesInfringement by enabling/facilitating activities Art. 63 UPCAMarketing authorisation as infringing act

Dokumente